[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

AU2003901647A0 - Novel Condensed Furan Compounds and Pharmaceutical Use Thereof - Google Patents

Novel Condensed Furan Compounds and Pharmaceutical Use Thereof

Info

Publication number
AU2003901647A0
AU2003901647A0 AU2003901647A AU2003901647A AU2003901647A0 AU 2003901647 A0 AU2003901647 A0 AU 2003901647A0 AU 2003901647 A AU2003901647 A AU 2003901647A AU 2003901647 A AU2003901647 A AU 2003901647A AU 2003901647 A0 AU2003901647 A0 AU 2003901647A0
Authority
AU
Australia
Prior art keywords
pharmaceutical use
furan compounds
novel condensed
condensed furan
novel
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003901647A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fujisawa Pharmaceutical Co Ltd
Original Assignee
Fujisawa Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fujisawa Pharmaceutical Co Ltd filed Critical Fujisawa Pharmaceutical Co Ltd
Priority to AU2003901647A priority Critical patent/AU2003901647A0/en
Publication of AU2003901647A0 publication Critical patent/AU2003901647A0/en
Priority to PCT/JP2004/003435 priority patent/WO2004089939A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Neurology (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU2003901647A 2003-04-04 2003-04-04 Novel Condensed Furan Compounds and Pharmaceutical Use Thereof Abandoned AU2003901647A0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
AU2003901647A AU2003901647A0 (en) 2003-04-04 2003-04-04 Novel Condensed Furan Compounds and Pharmaceutical Use Thereof
PCT/JP2004/003435 WO2004089939A1 (en) 2003-04-04 2004-03-15 Condensed furan derivatives as adenosine antagonists

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AU2003901647A AU2003901647A0 (en) 2003-04-04 2003-04-04 Novel Condensed Furan Compounds and Pharmaceutical Use Thereof

Publications (1)

Publication Number Publication Date
AU2003901647A0 true AU2003901647A0 (en) 2003-05-01

Family

ID=31500690

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003901647A Abandoned AU2003901647A0 (en) 2003-04-04 2003-04-04 Novel Condensed Furan Compounds and Pharmaceutical Use Thereof

Country Status (2)

Country Link
AU (1) AU2003901647A0 (en)
WO (1) WO2004089939A1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2562126A1 (en) * 2004-04-01 2005-10-13 Astellas Pharma Inc. Pyrazine derivatives and pharmaceutical use thereof
GB0806656D0 (en) * 2008-04-11 2008-05-14 Karobio Ab Novel estrogen receptor ligands
GB201113538D0 (en) 2011-08-04 2011-09-21 Karobio Ab Novel estrogen receptor ligands
KR101684950B1 (en) 2012-07-23 2016-12-12 주식회사유한양행 Furan-containing fused cyclic compound or its salt and pharmaceutical composition comprising the same
SG11202109568TA (en) * 2019-03-20 2021-10-28 Goldfinch Bio Inc Pyridazinones and methods of use thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPO111096A0 (en) * 1996-07-18 1996-08-08 Fujisawa Pharmaceutical Co., Ltd. New compound
AUPP672198A0 (en) * 1998-10-23 1998-11-19 Fujisawa Pharmaceutical Co., Ltd. Pyrazolopyridine compound and pharmaceutical use thereof

Also Published As

Publication number Publication date
WO2004089939A1 (en) 2004-10-21

Similar Documents

Publication Publication Date Title
IL176248A0 (en) N-substituted-n-sulfonylaminocyclopropane compounds and pharmaceutical use thereof
AU2003261935A1 (en) Furan or thiophene derivative and medicinal use thereof
IL170758A0 (en) 7-amino-isoindolyl compounds and their pharmaceutical uses
AU2003291103A1 (en) Pharmaceutical composition
AU2003246810A1 (en) Diphenylpyridine derivatives, the preparation thereof, and pharmaceutical compositions containing said derivatives
AU2003278393A1 (en) New use for pharmaceutical composition
IL164547A0 (en) Pharmaceutical composition
AU2003250372A1 (en) Pharmaceutical composition
AU2002302147A1 (en) Pharmaceutical composition
IL172814A0 (en) Novel solid pharmaceutical composition comprising amisulpride
EP1556056A4 (en) X-nitro compounds, pharmaceutical compositions thereof and uses therof
AU2003901647A0 (en) Novel Condensed Furan Compounds and Pharmaceutical Use Thereof
HK1065477A1 (en) Pharmaceutical composition
AU2003295057A1 (en) Novel lipophilic compounds and uses thereof
AU2002342940A1 (en) New pharmaceutical compounds
AUPR529701A0 (en) Pharmaceutical composition
AUPS188302A0 (en) Pharmaceutical composition
AU2002361450A1 (en) Novel pharmaceutical
AU2003207055A1 (en) Novel drugs for external use
GB0217703D0 (en) Pharmaceutical composition
AU2003902322A0 (en) Pharmaceutical composition
AUPS124202A0 (en) Pharmaceutical composition
AUPS167102A0 (en) Pharmaceutical composition
AU2002100921A4 (en) Pharmaceutical composition
AU2003266526A1 (en) Medicinal composition